SBIR/STTR Research Award

Immunoaffinity Isolation of Phosphopeptides

Award identifier d66df883fe8de44c9088e565dd8b225ad3597153ac21eef434b3d2940b5e2469Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$120,000

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CELL SIGNALING TECHNOLOGY, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
DEUMJK7A3NH4
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Among post-translational modifications, protein phosphorylation is particularly relevant to cancer biology and therapy. However, despite advances in proteomics, it is still difficult to pinpoint phosphorylation sites in proteins. The long-term goal of this project is to develop and commercialize a multiplexed method for isolating and identifying phosphorylation sites based on phosphorylation-specific antibodies. This method would contribute to the development of a new generation of drugs tailored to inhibit specific protein kinases with roles in cancer by identifying new phosphorylation sites that could become targets for cancer diagnosis and treatment. During Phase I we will develop an immunoaffinity method for multiplexed phosphopeptide sorting. We will address key issues qualitatively to establish the method and its tools. We will show that the method can isolate phosphopeptides from simple model systems and complex biological samples, evaluating results with MALDI-TOF mass spectrometry. We will show that isolated peptides can be further analyzed to identify sequences and phosphorylation sites using capillary LC-MS/MS, MS3, chemical modification, and enzymatic treatment as needed to generate informative spectra. Novel, ambiguous, or especially important phosphorylation sites will be confirmed by comparing the spectra of peptides synthesized to have the identified sequences and phosphorylation sites to the spectra of the isolated, natural phosphopeptides.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

8 SBIR/STTR records share this UEI (2002–2007). Reported award amounts total $4,232,395. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.